Joacim Borg
Directeur/Membre du Conseil chez OS Therapies, Inc.
Profil
Joacim Borg is currently a Director at OS Therapies, Inc. He previously worked as a Director at Heart of Brands AB.
Borg received an undergraduate degree from Bentley University.
Postes actifs de Joacim Borg
Sociétés | Poste | Début |
---|---|---|
OS Therapies, Inc.
OS Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services OS Therapies, Inc. operates as a clinical stage biopharmaceutical company. It engages in identification, development, and commercialization of treatments for Osteosarcoma and other related diseases. The company was founded by Paul A. Romness on April 12, 2018 and is headquartered in Rockville, MD. | Directeur/Membre du Conseil | 01/07/2022 |
Anciens postes connus de Joacim Borg
Sociétés | Poste | Fin |
---|---|---|
Heart of Brands AB
Heart of Brands AB Apparel/FootwearConsumer Non-Durables Heart of Brands AB manufactures and sells clothing and accessories. The firm's brands include ELLE prêt-a-porter, POUR, Stylesnob, Pinko, Zetterberg Collection, Nina Ricci, Pierre Cardin, Pierre Clarence and Dormeuil och Fruit of the Loom. The company was founded in October 2006 and is headquartered in Stockholm, Sweden. | Directeur/Membre du Conseil | 11/08/2010 |
Formation de Joacim Borg
Bentley University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Heart of Brands AB
Heart of Brands AB Apparel/FootwearConsumer Non-Durables Heart of Brands AB manufactures and sells clothing and accessories. The firm's brands include ELLE prêt-a-porter, POUR, Stylesnob, Pinko, Zetterberg Collection, Nina Ricci, Pierre Cardin, Pierre Clarence and Dormeuil och Fruit of the Loom. The company was founded in October 2006 and is headquartered in Stockholm, Sweden. | Consumer Non-Durables |
OS Therapies, Inc.
OS Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services OS Therapies, Inc. operates as a clinical stage biopharmaceutical company. It engages in identification, development, and commercialization of treatments for Osteosarcoma and other related diseases. The company was founded by Paul A. Romness on April 12, 2018 and is headquartered in Rockville, MD. | Commercial Services |